Cardiol Therapeutics Class Stock Price Prediction

CRDL Stock  USD 1.81  0.01  0.56%   
As of now, the RSI of Cardiol Therapeutics' share price is approaching 47 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cardiol Therapeutics, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
Cardiol Therapeutics stock price prediction is an act of determining the future value of Cardiol Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cardiol Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cardiol Therapeutics and does not consider all of the tangible or intangible factors available from Cardiol Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Cardiol Therapeutics Class, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Cardiol Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.08)
EPS Estimate Current Year
(0.32)
EPS Estimate Next Year
(0.35)
Wall Street Target Price
5.96
EPS Estimate Current Quarter
(0.09)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cardiol Therapeutics based on different types of headlines from major news networks to social media. The Cardiol stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cardiol Therapeutics over a specific investment horizon. Using Cardiol Therapeutics hype-based prediction, you can estimate the value of Cardiol Therapeutics Class from the perspective of Cardiol Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cardiol Therapeutics using Cardiol Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cardiol using crowd psychology based on the activity and movement of Cardiol Therapeutics' stock price.

Cardiol Therapeutics Implied Volatility

    
  128.21  
Cardiol Therapeutics' implied volatility exposes the market's sentiment of Cardiol Therapeutics Class stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardiol Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardiol Therapeutics stock will not fluctuate a lot when Cardiol Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Cardiol Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cardiol Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cardiol because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cardiol Therapeutics after-hype prediction price

    
  USD 2.19  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Cardiol Therapeutics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiol Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.122.4611.04
Details
Naive
Forecast
LowNextHigh
0.042.0810.66
Details
3 Analysts
Consensus
LowTargetHigh
4.094.494.98
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.09-0.09-0.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cardiol Therapeutics. Your research has to be compared to or analyzed against Cardiol Therapeutics' peers to derive any actionable benefits. When done correctly, Cardiol Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cardiol Therapeutics.

Cardiol Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Cardiol Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cardiol Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cardiol Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cardiol Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Cardiol Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cardiol Therapeutics' historical news coverage. Cardiol Therapeutics' after-hype downside and upside margins for the prediction period are 0.11 and 10.77, respectively. We have considered Cardiol Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.81
2.19
After-hype Price
10.77
Upside
Cardiol Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Cardiol Therapeutics is based on 3 months time horizon.

Cardiol Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cardiol Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardiol Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cardiol Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.52 
8.58
  0.38 
  0.23 
4 Events / Month
3 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.81
2.19
20.99 
3,432  
Notes

Cardiol Therapeutics Hype Timeline

Cardiol Therapeutics is currently traded for 1.81. The entity has historical hype elasticity of 0.38, and average elasticity to hype of competition of -0.23. Cardiol is forecasted to increase in value after the next headline, with the price projected to jump to 2.19 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 20.99%, whereas the daily expected return is currently at 1.52%. The volatility of related hype on Cardiol Therapeutics is about 5595.65%, with the expected price after the next announcement by competition of 1.58. The company currently holds 72.87 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Cardiol Therapeutics has a current ratio of 6.35, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cardiol Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Cardiol Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardiol Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardiol to invest in growth at high rates of return. When we think about Cardiol Therapeutics' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 4 days.
Check out Cardiol Therapeutics Basic Forecasting Models to cross-verify your projections.

Cardiol Therapeutics Related Hype Analysis

Having access to credible news sources related to Cardiol Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cardiol Therapeutics' future price movements. Getting to know how Cardiol Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cardiol Therapeutics may potentially react to the hype associated with one of its peers.

Cardiol Therapeutics Additional Predictive Modules

Most predictive techniques to examine Cardiol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardiol using various technical indicators. When you analyze Cardiol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cardiol Therapeutics Predictive Indicators

The successful prediction of Cardiol Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cardiol Therapeutics Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cardiol Therapeutics based on analysis of Cardiol Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cardiol Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cardiol Therapeutics's related companies.
 2010 2023 2024 (projected)
Days Of Sales Outstanding1.9K1.7K1.5K
Days Of Inventory Outstanding2.7K32.8631.21

Story Coverage note for Cardiol Therapeutics

The number of cover stories for Cardiol Therapeutics depends on current market conditions and Cardiol Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cardiol Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cardiol Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cardiol Therapeutics Short Properties

Cardiol Therapeutics' future price predictability will typically decrease when Cardiol Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cardiol Therapeutics Class often depends not only on the future outlook of the potential Cardiol Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiol Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding62.5 M
Cash And Short Term Investments59.5 M
When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics' future performance. For an informed investment choice regarding Cardiol Stock, refer to the following important reports:
Check out Cardiol Therapeutics Basic Forecasting Models to cross-verify your projections.
Note that the Cardiol Therapeutics information on this page should be used as a complementary analysis to other Cardiol Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Cardiol Stock analysis

When running Cardiol Therapeutics' price analysis, check to measure Cardiol Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiol Therapeutics is operating at the current time. Most of Cardiol Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cardiol Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiol Therapeutics' price. Additionally, you may evaluate how the addition of Cardiol Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Cardiol Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. If investors know Cardiol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiol Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Return On Assets
(0.35)
Return On Equity
(0.60)
The market value of Cardiol Therapeutics is measured differently than its book value, which is the value of Cardiol that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiol Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cardiol Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiol Therapeutics' market value can be influenced by many factors that don't directly affect Cardiol Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.